HROW - Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15 revenue of $36.36M misses by $1.5M
2024-03-20 01:11:43 ET
More on Harrow Health
- Harrow's Drug Iheezo Is Off To A Great Start
- Harrow: Hedge Downside Risk With The 11.5% Yielding Baby Bonds
- Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity
- Harrow says dry eye drug Vevye now available in US